Delahunt B, Bethwaite P B, Nacey J N, Ribas J L
Department of Pathology, Wellington School of Medicine, University of Otago, New Zealand.
J Pathol. 1993 Aug;170(4):471-7. doi: 10.1002/path.1711700411.
Proliferating cell nuclear antigen (PCNA) expression in renal cell carcinoma (RCC) was determined by immunohistochemical staining using the PC10 clone. PCNA indices ranged from 2.4 to 53.1 per cent with mean indices of 12.6, 19.0, and 31.6 per cent for grades 1 to 3 RCC and 31.9 per cent for sarcomatoid RCC. There was a significant difference between the indices of grades 1 and 3 and grades 2 and 3 tumours and between grades 1 and 2 RCC and sarcomatoid RCC. AgNOR scores and mitotic indices were determined for each tumour and comparison of PCNA indices with mean AgNOR scores and mitotic indices showed only a weak correlation (PCNA/AgNOR r = 0.406, PCNA/mitotic index r = 0.315). Tumours were divided according to PCNA index (< or = 18 per cent and > 18 per cent) and there was a significant difference in survival between the two groups, for all cases, and for each of the Robson stages. Multivariate analysis using Cox's proportional hazard model showed PCNA index, tumour stage, and mean AgNOR score to be independent predictors of survival, while tumour grade and mitotic index were found to be dependent variables.
采用PC10克隆通过免疫组织化学染色法测定肾细胞癌(RCC)中增殖细胞核抗原(PCNA)的表达。PCNA指数范围为2.4%至53.1%,1至3级RCC的平均指数分别为12.6%、19.0%和31.6%,肉瘤样RCC为31.9%。1级与3级、2级与3级肿瘤的指数之间以及1级与2级RCC和肉瘤样RCC之间存在显著差异。测定每个肿瘤的银染核仁组织区(AgNOR)评分和有丝分裂指数,PCNA指数与平均AgNOR评分和有丝分裂指数的比较显示仅存在弱相关性(PCNA/AgNOR r = 0.406,PCNA/有丝分裂指数r = 0.315)。根据PCNA指数(≤18%和>18%)对肿瘤进行分组,两组之间在所有病例以及每个罗布森分期的生存率上均存在显著差异。使用考克斯比例风险模型进行多变量分析显示,PCNA指数、肿瘤分期和平均AgNOR评分是生存的独立预测因素,而肿瘤分级和有丝分裂指数是因变量。